Home Neoplasma 2015 Neoplasma Vol.62, No.3, p.345-352, 2015

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.62, No.3, p.345-352, 2015

Title: Modification of microflora imbalance: future directions for prevention and treatment of colorectal cancer?
Author: S. CIERNIKOVA, M. MEGO, K. HAINOVA, Z. ADAMCIKOVA, V. STEVURKOVA, V. ZAJAC

Abstract: Increasing incidence and mortality of colorectal cancer brings the necessity to uncover new possibilities in the prevention, diagnosis and treatment. The microbiome as the collective genetic material of the microflora, overexceed the number of genes in the human genome and is unique for each individual. Due to the benefits providing for the host and mainly for immediate interaction with the host immune system, a gastrointestinal microflora can be considered „cardinal microbiome“. Host-microbial relations includes symbiotic, pathogenic and competitive interactions. Causal role of gastrointestinal microflora in colorectal carcinogenesis is still not well determined. This minireview is focused on current evidence in understanding the role of bacteria in colorectal carcinogenesis, the impact of bacterial dysbiosis on tumor formation, and ability of probiotics and bacterial vectors to modulate the gastrointestinal microflora as prevention and therapy tool in colorectal cancer.

Keywords: colorectal cancer, intestinal bacteria, microflora dysbiosis, cancer prevention and treatment, probiotics, bacterial vectors
Published online: 01-Apr-2015
Year: 2015, Volume: 62, Issue: 3 Page From: 345, Page To: 352
doi:10.4149/neo_2015_042


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.